UNSPSC 41202005: Beta-glucan serological assays

In this classification, Beta-glucan serological assays are devices used in test to identify specific Beta-glucan serological assays antibodies in serum. US FDA regulates Beta-glucan serological assays under 21 CFR 866.3050 and under FDA product code NQZ.

UNSPSC 41202005 Beta-glucan serological assays is a Commodity code used by state and local health agencies to procure HIV and Syphilis testing services, though recent posted solicitations show significant misalignment between the code's nominal scope and actual procurement activity. The recent state and local opportunities under this code encompass HIV and Syphilis reagents, rapid diagnostic test kits, fourth-generation combination screening assays, forensic serology analysis, offender drug-testing services with immunoassay screening and confirmation protocols, and related laboratory diagnostic supplies and instrumentation. Issuing bodies include state departments of public health (Illinois Department of Public Health Division of Laboratories, Texas Department of Criminal Justice), county supervision and corrections departments (Collin County Community Supervision and Corrections), city public health programs (City of Austin), and university health centers (University of Houston). State health laboratory procurement dominates the recent activity, driven by compliance requirements for CLIA certification, SAMHSA accreditation, and FBI-CJIS security standards.

Geographic concentration is heaviest in Texas and Illinois, with Texas showing significant recent activity across Collin County offender testing and TDCJ forensic serology procurement, and Illinois documenting multiple emergency and competitive procurements through the state Department of Public Health for HIV, Syphilis, and Hepatitis screening at Jackson and Carbondale laboratories. Representative recent opportunities include Collin County Community Supervision and Corrections Department's RFP 2026-327 for offender specimen collection and drug testing services (due July 23, 2026, estimated value $600,000 over two years with optional renewals), City of Austin's IFB 9100AAM1023 for rapid HIV test kits (due July 17, 2026), Illinois Department of Public Health's IFB for Hepatitis/HIV/Syphilis fourth-generation combination screening assays and instrumentation (due March 16, 2026, five-year contract with potential five-year renewal), and Texas Department of Criminal Justice's RFP 696-IG-26-P034 for forensic analysis including serology and DNA testing for inmate evidence (due May 13, 2026, one-year base with four optional one-year renewals). The code shows active but narrowly distributed procurement volume across public health and criminal justice agencies; opportunities reflect both competitive bidding for consumables and services and sole-source emergency buys for manufacturer-specific reagents and instrumentation.